Theratechnologies Inc
NASDAQ:THTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Theratechnologies Inc
NASDAQ:THTX
|
CA |
|
S
|
Softcat PLC
F:SF5
|
UK |
|
M
|
Mulpha International Bhd
KLSE:MULPHA
|
MY |
|
Campbell Soup Co
NYSE:CPB
|
US |
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
Cbrain A/S
F:C6F
|
DK |
|
P
|
Pearson PLC
F:PES
|
UK |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
Vocento SA
F:VON
|
ES |
|
Expedia Group Inc
NASDAQ:EXPE
|
US |
|
Wacker Chemie AG
F:WCH
|
DE |
|
Eastnine AB (publ)
F:O060
|
SE |
|
S
|
Schlumberger NV
XHAM:SCL
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
IDX:BBRI
|
ID |
|
Engineers India Ltd
NSE:ENGINERSIN
|
IN |
|
Information Services Group Inc
NASDAQ:III
|
US |
|
T
|
TX Group AG
XBER:TAMN
|
CH |
|
Honeywell International Inc
NASDAQ:HON
|
US |
|
A
|
American Express Co
SGO:AXP
|
US |
|
Horiba Ltd
TSE:6856
|
JP |
|
3
|
3M Co
SIX:MMM
|
US |
Bankruptcy Probability
Theratechnologies Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Theratechnologies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Theratechnologies Inc
TSX:TH
|
205.5m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
372.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
164B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Theratechnologies Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Theratechnologies Inc has total debt of 40m USD. This includes both short-term (0 USD) and long-term (40m USD) debt.
You can find a full breakdown on its Balance Sheet.
